# In Vivo Efficacy of Contact Lens Drug-Delivery Systems in Glaucoma Management. A Systematic Review
## 5 Conclusions
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. _Biomaterials_**2014**, _35_, 432-439. [CrossRef] [PubMed]
* [PERSON] et al. (2016) [PERSON], [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys. _Ophthalmology_**2016**, _123_, 2085-2092. [CrossRef]
* [PERSON] et al. (2010) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery. _J. Control Release_**2016**, _226_, 47-56. [CrossRef]
* [PERSON] et al. (2010) [PERSON]; [PERSON]; [PERSON] Preparation and evaluation of a contact lens vehicle for puerarin delivery. _J. Biomater. Sci. Polym. Ed._**2010**, _21_, 271-288. [CrossRef] [PubMed]
* [PERSON] et al. (2019) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation. _Acta Biomater._**2019**, _86_, 350-362. [CrossRef]
* [PERSON] et al. (2019) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma. _J. Control Release_**2019**, _305_, 18-28. [CrossRef]
* [PERSON] and IMM (1960) [PERSON]; [PERSON] Hydrodynamic Cells for Biological Use. _Nature_**1960**, _185_, 117-118. [CrossRef]
* [PERSON] (1977) [PERSON]; [PERSON] Pilocarpine administration by contact lens. _Trans Ophthalmal. Soc. UK_**1977**, _97_, 162-163. [PubMed]
* [PERSON] et al. (2020) [PERSON]; [PERSON]; [PERSON]; [PERSON] Latanoprost uptake and release from commercial contact lenses. _J. Biomater. Sci. Polym. Ed._**2020**, _31_, 1-19. [CrossRef]
* [PERSON] et al. (2015) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Sustained drug release by contact lenses for glaucoma treatment-a review. _J. Control Release_**2015**, _202_, 76-82. [CrossRef] [PubMed]
* [PERSON] et al. (2016) [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON] Ocular Drug Delivery through pHEMA-Hydrogel Contact Lenses Co-Loaded with Lipophilic Vitamins. _Sci. Rep._**2016**, \(6\), 34194. [CrossRef]
* [PERSON] et al. (2002) [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] Soft contact lenses capable of sustained delivery of timolol. _J. Pharm. Sci._**2002**, _91_, 2182-2192. [CrossRef] [PubMed]
* [PERSON] and [PERSON] (2010) [PERSON]; [PERSON] Molecularly imprinted therapeutic contact lenses. _Expert Opin. Drug Deliv._**2010**, \(7\), 765-780. [CrossRef]
* [PERSON] et al. (2006) [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] Imprinted soft contact lenses as nonfloxacin delivery systems. _J. Control Release_**2006**, _113_, 236-244. [CrossRef]
* [PERSON] et al. (2010) [PERSON]; [PERSON]; [PERSON] Enhancing therapeutic loading and delaying transport via molecular imprinting and living/controlled polymerization. _AIChE J._**2010**, _56_, 268-279. [CrossRef]
* [PERSON] and [PERSON] (2009) [PERSON]; [PERSON] Controlled release of high molecular weight hyaluronic Acid from molecularly imprinted hydrogel contact lenses. _Pharm. Res._**2009**, _26_, 714-726. [CrossRef]
* [PERSON] et al. (2011) [PERSON]; [PERSON]; [PERSON] In vitro and in vivo evaluation of ketotifen fumarate-loaded silicone hydrogel contact lenses for ocular drug delivery. _Drug Deliv._**2011**, _18_, 150-158. [CrossRef]
* [PERSON] et al. (2012) [PERSON]; [PERSON]; [PERSON]; [PERSON] Controlled release of prednisolone acetate from molecularly imprinted hydrogel contact lenses. _J. Appl. Polym. Sci._**2012**, _126_, 387-394. [CrossRef]
* [PERSON] et al. (2020) [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON] Imprinted Contact Lenses for Ocular Administration of Antiviral Drugs. _Polymers (Basel)_**2020**, _12_, 2026.